Klotho/FGF23 axis mediates high phosphate‐induced vascular calcification in vascular smooth muscle cells via Wnt7b/β‐catenin pathway
2019 · The Kaohsiung Journal of Medical Sciences · 38 citations
https://doi.org/10.1002/kjm2.12072
C
Chengyun Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
88
Papers
1.6K
Citations
25
h-index
46
i10-index
Chengyun Xu is an academic researcher from Hangzhou First People's Hospital. The author has contributed to research in topics: Bone Metabolism and Diseases & Dialysis and Renal Disease Management & Parathyroid Disorders and Treatments. The author has an h-index of 25, co-authored 75 publications.
ORCID: 0000-0003-3747-3728Papers by this author
worksRhoA/Rock activation represents a new mechanism for inactivating Wnt/β-catenin signaling in the aging-associated bone loss
2021 · Cell Regeneration · 37 citations
https://doi.org/10.1186/s13619-020-00071-3
Long noncoding RNA NEAT1 sponges miR-129 to modulate renal fibrosis by regulation of collagen type I
2020 · American Journal of Physiology-Renal Physiology · 34 citations
https://doi.org/10.1152/ajprenal.00552.2019
Acute Respiratory Distress Syndrome: Bench‐to‐Bedside Approaches to Improve Drug Development
2018 · Clinical Pharmacology & Therapeutics · 27 citations
https://doi.org/10.1002/cpt.1034
Inhibition of p21-activated kinase 1 attenuates the cardinal features of asthma through suppressing the lymph node homing of dendritic cells
2018 · Biochemical Pharmacology · 14 citations
https://doi.org/10.1016/j.bcp.2018.06.012
Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma
2022 · Journal of Experimental & Clinical Cancer Research · 13 citations
https://doi.org/10.1186/s13046-022-02453-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat